Loading…
Dipna Pharmachem (BSE 543594)₹4.14−3.94%Pharmaceuticals
At the end of the Jun 2026 quarter, Dipna Pharmachem's shareholders were: promoters 9.10%, public 90.90%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 1,787 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Promoters | 57.16% | 9.95% | 9.95% | 9.95% | 9.95% | 9.10% | 9.10% | 9.10% |
| Public | 42.84% | 90.05% | 90.05% | 90.05% | 90.05% | 90.90% | 90.90% | 90.90% |
| Promoter shares pledged | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 1,077 | 1,806 | 2,651 | 1,996 | 1,741 | 1,740 | 1,716 | 1,787 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Keyur Dipakkumar Shah | Promoter | 9.08% | 0.00 |
| Ashok Dilipkumar Jain | Public | 4.30% | 0.00 |
| Kajal Ashok Jain | Public | 4.29% | 0.00 |
| Siddharth Poddar | Public | 4.13% | 0.00 |
| Namita Hemant Jain | Public | 3.58% | −0.61 |
| Teena Kirti Jain | Public | 3.25% | −0.49 |
| Vibha R Tripathi | Public | 2.61% | 0.00 |
| Sanjay Nirmal Jain Huf | Public | 2.44% | −0.07 |
| Neerita Sanjay jain | Public | 2.18% | −0.04 |
| Maheshbhai Jivanbhai Ramani | Public | 2.18% | 0.00 |
| Girish Ganesh Sathe | Public | 1.96% | 0.00 |
| Rajesh Tripathi | Public | 1.83% | +0.04 |
| Sunita Santosh Goenka | Public | 1.82% | 0.00 |
| Alka Jaysing Tambe | Public | 1.58% | 0.00 |
| Janhavi Santosh Ghadge | Public | 1.47% | 0.00 |
| Bageshri Santosh Kanitkar | Public | 1.41% | 0.00 |
| Ravi Bhushan Puri | Public | 1.17% | +0.04 |
| Falguni Yogendra Trivedi | Public | 1.15% | New |
| Nareshkumar Kapoorchand Jain | Public | 1.12% | 0.00 |
| Kaavya Agrawal | Public | 1.05% | New |
| Dipna Keyur Shah | Promoter | 0.01% | 0.00 |
| Hemant Naresh Jain Huf | Public | Exited | — |
| Viha Ashok Jain | Public | Exited | — |
Promoters held 9.10% of Dipna Pharmachem at the end of the Jun 2026 quarter, down 0.85 percentage points from 9.95% a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Dipna Pharmachem had 1,787 shareholders at the end of the Jun 2026 quarter, against 1,996 a year earlier.
Ashok Dilipkumar Jain (Public) held 4.30% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.